Home › Companies › CELLDEX THERAPEUTICS INC. › 2024-2025
Compiled from SEC Form N-PX filings and CELLDEX THERAPEUTICS INC.’s Form 8-K, filed 2025-06-06 (Item 5.07 on EDGAR). Page generated 02 October 2026.
Explore CELLDEX THERAPEUTICS INC. in the interactive database Compare manager voting policies
These tallies are CELLDEX THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2025-06-06 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Outcome |
|---|---|---|---|---|---|---|
| Elect Director: Anthony S. Marucci (Chief Executive Officer) | 54,056,360 | 60,785 | 164,073 | -- | 4,031,935 | Majority: yes |
| Elect Director: Keith L. Brownlie | 53,883,737 | 250,401 | 147,080 | -- | 4,031,935 | Majority: yes |
| Elect Director: Cheryl L. Cohen | 53,969,213 | 165,776 | 146,229 | -- | 4,031,935 | Majority: yes |
| Elect Director: Herbert J. Conrad | 53,051,316 | 1,082,802 | 147,100 | -- | 4,031,935 | Majority: yes |
| Elect Director: Rita I. Jain, M.D. | 53,914,572 | 207,007 | 159,639 | -- | 4,031,935 | Majority: yes |
| Elect Director: James J. Marino | 53,832,714 | 301,247 | 147,257 | -- | 4,031,935 | Majority: yes |
| Elect Director: Garry A. Neil, M.D. | 53,900,408 | 233,807 | 147,003 | -- | 4,031,935 | Majority: yes |
| Elect Director: Harry H. Penner, Jr. | 53,773,546 | 360,343 | 147,329 | -- | 4,031,935 | Majority: yes |
| Elect Director: Denice Torres | 54,104,937 | 29,828 | 146,453 | -- | 4,031,935 | Majority: yes |
| Proposal 2: The stockholders approved the ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025. | 58,043,825 | 119,347 | 149,981 | -- | -- | Majority: yes |
| Proposal 3: The stockholders approved an amendment to our 2021 Omnibus Equity Incentive Plan, including an increase in the number of the shares reserved for issuance thereunder by 2,000,000 shares to 9,500,000 shares. | 53,158,156 | 963,067 | 159,995 | -- | 4,031,935 | Majority: yes |
| Proposal 4: The stockholders voted to approve, on an advisory, non-binding basis, the compensation for the Company's named executive officers as disclosed in the Proxy Statement. | 53,482,418 | 626,666 | 172,134 | -- | 4,031,935 | Majority: yes |
Source: CELLDEX THERAPEUTICS INC., Form 8-K, filed with the SEC on 2025-06-06 — read the filing on EDGAR.
Each item below shows how the 190 asset managers that disclosed a CELLDEX THERAPEUTICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.
Meeting held 2025-06-05.
Combines 7 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
CELLDEX THERAPEUTICS INC.’s own tally for this item (“Proposal 4: The stockholders voted to approve, on an advisory, non-binding basis, the compensation for the Company's named executive officers as disclosed in the Proxy Statement.”): 53,482,418 for, 626,666 against, per its Form 8-K filed 2025-06-06 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 66,384,191 outstanding shares: 81% for, 1.0% against (82% of the company cast a for/against vote).
The 188 asset managers below cast 99% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the company's reported shares outstanding.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 10,962,838 | 0 | 0 | 0 | For |
| Vanguard | 9,292,922 | 0 | 0 | 0 | For |
| Wellington | 7,593,655 | 0 | 0 | 0 | For |
| T. Rowe Price | 5,949,542 | 0 | 0 | 0 | For |
| Kynam Capital Management, LP | 0 | 0 | 4,605,007 | 0 | Abstain |
| BlackRock | 3,756,961 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 3,736,784 | 0 | 0 | 0 | For |
| Commodore Capital LP | 3,680,000 | 0 | 0 | 0 | For |
| State Street | 3,306,329 | 2,293 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 1,609,488 | 0 | 0 | 0 | For |
| Novo Holdings A/S | 1,200,000 | 0 | 0 | 0 | For |
| Woodline Partners LP | 1,188,429 | 0 | 0 | 0 | For |
| Charles Schwab | 1,075,667 | 0 | 0 | 0 | For |
| PICTET ASSET MANAGEMENT SA | 1,028,947 | 0 | 0 | 0 | For |
| American Century | 1,019,727 | 0 | 0 | 0 | For |
| Rock Springs Capital Management LP | 812,653 | 0 | 0 | 0 | For |
| Deep Track Capital, LP | 767,389 | 0 | 0 | 0 | For |
| Eversept Partners, LP | 696,499 | 0 | 0 | 0 | For |
| Fisher Asset Management, LLC | 651,061 | 0 | 0 | 0 | For |
| Redmile Group, LLC | 550,966 | 0 | 0 | 0 | For |
| 5AM Venture Management, LLC | 497,270 | 0 | 0 | 0 | For |
| Hartford | 460,983 | 0 | 0 | 0 | For |
| Northern Trust | 455,951 | 0 | 0 | 0 | For |
| Nuveen | 429,126 | 0 | 0 | 0 | For |
| TIAA | 426,710 | 0 | 0 | 0 | For |
Showing the 25 largest of 188 asset managers. See all 188 in the interactive database.
Meeting held 2025-06-05.
Combines 3 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
CELLDEX THERAPEUTICS INC.’s own tally for this item (“Proposal 3: The stockholders approved an amendment to our 2021 Omnibus Equity Incentive Plan, including an increase in the number of the shares reserved for issuance thereunder by 2,000,000 shares to 9,500,000 shares.”): 53,158,156 for, 963,067 against, per its Form 8-K filed 2025-06-06 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 66,384,191 outstanding shares: 80% for, 1% against (82% of the company cast a for/against vote).
The 55 asset managers below cast 98% of the shares they voted on this item FOR (27,605,792 for, 531,091 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 9,127,282 | 0 | 0 | 0 | For |
| Fidelity | 5,686,474 | 0 | 0 | 0 | For |
| Kynam Capital Management, LP | 0 | 0 | 4,605,007 | 0 | Abstain |
| MUTUAL FUND SERIES TRUST | 3,736,784 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,525,742 | 0 | 0 | 0 | For |
| BlackRock | 1,930,877 | 0 | 0 | 0 | For |
| State Street | 1,012,770 | 40 | 0 | 0 | For |
| Eversept Partners, LP | 696,499 | 0 | 0 | 0 | For |
| Charles Schwab | 537,823 | 0 | 0 | 0 | For |
| American Century | 0 | 496,205 | 0 | 0 | Against |
| Hartford | 460,983 | 0 | 0 | 0 | For |
| TIAA | 426,710 | 0 | 0 | 0 | For |
| Equitable | 179,048 | 0 | 0 | 0 | For |
| Northwestern Mutual | 115,697 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 111,060 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 108,915 | 0 | 0 | 0 | For |
| Brighthouse | 96,363 | 0 | 9,367 | 0 | For |
| John Hancock | 96,110 | 0 | 0 | 0 | For |
| DWS | 95,780 | 0 | 0 | 0 | For |
| JPMorgan | 77,880 | 0 | 0 | 0 | For |
| Lincoln Financial | 52,768 | 0 | 0 | 0 | For |
| MassMutual | 40,504 | 0 | 0 | 0 | For |
| New York Life | 38,343 | 0 | 0 | 0 | For |
| Global X | 37,966 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 15,624 | 19,391 | 0 | 0 | Against |
Showing the 25 largest of 55 asset managers. See all 55 in the interactive database.
Meeting held 2025-06-05.
Combines 2 wordings of this item as funds reported it.
99.8% Majority: yes · of votes cast
CELLDEX THERAPEUTICS INC.’s own tally for this item (“Elect Director: Anthony S. Marucci (Chief Executive Officer)”): 54,056,360 for, 60,785 against, per its Form 8-K filed 2025-06-06 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 66,384,191 outstanding shares: 81% for, 0.1% against (82% of the company cast a for/against vote).
The 52 asset managers below cast 100% of the shares they voted on this item FOR (27,408,184 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 9,127,282 | 0 | 0 | 0 | For |
| Fidelity | 5,686,474 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 3,736,784 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,525,742 | 0 | 0 | 0 | For |
| BlackRock | 1,930,877 | 0 | 0 | 0 | For |
| State Street | 1,012,810 | 0 | 0 | 0 | For |
| Charles Schwab | 537,823 | 0 | 0 | 0 | For |
| American Century | 496,205 | 0 | 0 | 0 | For |
| Hartford | 460,983 | 0 | 0 | 0 | For |
| TIAA | 426,710 | 0 | 0 | 0 | For |
| Equitable | 179,048 | 0 | 0 | 0 | For |
| Northwestern Mutual | 115,697 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 111,060 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 108,915 | 0 | 0 | 0 | For |
| Brighthouse | 96,363 | 0 | 9,367 | 0 | For |
| John Hancock | 96,110 | 0 | 0 | 0 | For |
| DWS | 95,780 | 0 | 0 | 0 | For |
| JPMorgan | 77,880 | 0 | 0 | 0 | For |
| Lincoln Financial | 52,768 | 0 | 0 | 0 | For |
| MassMutual | 40,504 | 0 | 0 | 0 | For |
| New York Life | 38,343 | 0 | 0 | 0 | For |
| Global X | 37,966 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 35,015 | 0 | 0 | 0 | For |
| ProShares | 32,980 | 0 | 0 | 0 | For |
| Transamerica | 32,668 | 0 | 0 | 0 | For |
Showing the 25 largest of 52 asset managers. See all 52 in the interactive database.
Meeting held 2025-06-05.
Combines 2 wordings of this item as funds reported it.
99.6% Majority: yes · of votes cast
CELLDEX THERAPEUTICS INC.’s own tally for this item (“Elect Director: Cheryl L. Cohen”): 53,969,213 for, 165,776 against, per its Form 8-K filed 2025-06-06 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 66,384,191 outstanding shares: 81% for, 0.3% against (82% of the company cast a for/against vote).
The 52 asset managers below cast 99.9% of the shares they voted on this item FOR (27,407,017 for, 1,167 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 9,127,282 | 0 | 0 | 0 | For |
| Fidelity | 5,686,474 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 3,736,784 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,525,742 | 0 | 0 | 0 | For |
| BlackRock | 1,930,877 | 0 | 0 | 0 | For |
| State Street | 1,012,810 | 0 | 0 | 0 | For |
| Charles Schwab | 537,823 | 0 | 0 | 0 | For |
| American Century | 496,205 | 0 | 0 | 0 | For |
| Hartford | 460,983 | 0 | 0 | 0 | For |
| TIAA | 426,710 | 0 | 0 | 0 | For |
| Equitable | 179,048 | 0 | 0 | 0 | For |
| Northwestern Mutual | 115,697 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 111,060 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 108,915 | 0 | 0 | 0 | For |
| Brighthouse | 96,363 | 0 | 9,367 | 0 | For |
| John Hancock | 96,110 | 0 | 0 | 0 | For |
| DWS | 95,780 | 0 | 0 | 0 | For |
| JPMorgan | 77,880 | 0 | 0 | 0 | For |
| Lincoln Financial | 52,768 | 0 | 0 | 0 | For |
| MassMutual | 40,504 | 0 | 0 | 0 | For |
| New York Life | 38,343 | 0 | 0 | 0 | For |
| Global X | 37,966 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 35,015 | 0 | 0 | 0 | For |
| ProShares | 32,980 | 0 | 0 | 0 | For |
| Transamerica | 32,668 | 0 | 0 | 0 | For |
Showing the 25 largest of 52 asset managers. See all 52 in the interactive database.
Meeting held 2025-06-05.
Combines 2 wordings of this item as funds reported it.
99.9% Majority: yes · of votes cast
CELLDEX THERAPEUTICS INC.’s own tally for this item (“Elect Director: Denice Torres”): 54,104,937 for, 29,828 against, per its Form 8-K filed 2025-06-06 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 66,384,191 outstanding shares: 82% for, 0.1% against (82% of the company cast a for/against vote).
The 52 asset managers below cast 100% of the shares they voted on this item FOR (27,408,184 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 9,127,282 | 0 | 0 | 0 | For |
| Fidelity | 5,686,474 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 3,736,784 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,525,742 | 0 | 0 | 0 | For |
| BlackRock | 1,930,877 | 0 | 0 | 0 | For |
| State Street | 1,012,810 | 0 | 0 | 0 | For |
| Charles Schwab | 537,823 | 0 | 0 | 0 | For |
| American Century | 496,205 | 0 | 0 | 0 | For |
| Hartford | 460,983 | 0 | 0 | 0 | For |
| TIAA | 426,710 | 0 | 0 | 0 | For |
| Equitable | 179,048 | 0 | 0 | 0 | For |
| Northwestern Mutual | 115,697 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 111,060 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 108,915 | 0 | 0 | 0 | For |
| Brighthouse | 96,363 | 0 | 9,367 | 0 | For |
| John Hancock | 96,110 | 0 | 0 | 0 | For |
| DWS | 95,780 | 0 | 0 | 0 | For |
| JPMorgan | 77,880 | 0 | 0 | 0 | For |
| Lincoln Financial | 52,768 | 0 | 0 | 0 | For |
| MassMutual | 40,504 | 0 | 0 | 0 | For |
| New York Life | 38,343 | 0 | 0 | 0 | For |
| Global X | 37,966 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 35,015 | 0 | 0 | 0 | For |
| ProShares | 32,980 | 0 | 0 | 0 | For |
| Transamerica | 32,668 | 0 | 0 | 0 | For |
Showing the 25 largest of 52 asset managers. See all 52 in the interactive database.
Meeting held 2025-06-05.
Combines 4 wordings of this item as funds reported it.
99.5% Majority: yes · of votes cast
CELLDEX THERAPEUTICS INC.’s own tally for this item (“Elect Director: Garry A. Neil, M.D.”): 53,900,408 for, 233,807 against, per its Form 8-K filed 2025-06-06 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 66,384,191 outstanding shares: 81% for, 0.4% against (82% of the company cast a for/against vote).
The 52 asset managers below cast 100% of the shares they voted on this item FOR (27,408,184 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 9,127,282 | 0 | 0 | 0 | For |
| Fidelity | 5,686,474 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 3,736,784 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,525,742 | 0 | 0 | 0 | For |
| BlackRock | 1,930,877 | 0 | 0 | 0 | For |
| State Street | 1,012,810 | 0 | 0 | 0 | For |
| Charles Schwab | 537,823 | 0 | 0 | 0 | For |
| American Century | 496,205 | 0 | 0 | 0 | For |
| Hartford | 460,983 | 0 | 0 | 0 | For |
| TIAA | 426,710 | 0 | 0 | 0 | For |
| Equitable | 179,048 | 0 | 0 | 0 | For |
| Northwestern Mutual | 115,697 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 111,060 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 108,915 | 0 | 0 | 0 | For |
| Brighthouse | 96,363 | 0 | 9,367 | 0 | For |
| John Hancock | 96,110 | 0 | 0 | 0 | For |
| DWS | 95,780 | 0 | 0 | 0 | For |
| JPMorgan | 77,880 | 0 | 0 | 0 | For |
| Lincoln Financial | 52,768 | 0 | 0 | 0 | For |
| MassMutual | 40,504 | 0 | 0 | 0 | For |
| New York Life | 38,343 | 0 | 0 | 0 | For |
| Global X | 37,966 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 35,015 | 0 | 0 | 0 | For |
| ProShares | 32,980 | 0 | 0 | 0 | For |
| Transamerica | 32,668 | 0 | 0 | 0 | For |
Showing the 25 largest of 52 asset managers. See all 52 in the interactive database.
Meeting held 2025-06-05.
Combines 2 wordings of this item as funds reported it.
99.3% Majority: yes · of votes cast
CELLDEX THERAPEUTICS INC.’s own tally for this item (“Elect Director: Harry H. Penner, Jr.”): 53,773,546 for, 360,343 against, per its Form 8-K filed 2025-06-06 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 66,384,191 outstanding shares: 81% for, 0.6% against (82% of the company cast a for/against vote).
The 52 asset managers below cast 99.9% of the shares they voted on this item FOR (27,387,586 for, 20,598 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 9,127,282 | 0 | 0 | 0 | For |
| Fidelity | 5,686,474 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 3,736,784 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,525,742 | 0 | 0 | 0 | For |
| BlackRock | 1,930,877 | 0 | 0 | 0 | For |
| State Street | 1,012,770 | 40 | 0 | 0 | For |
| Charles Schwab | 537,823 | 0 | 0 | 0 | For |
| American Century | 496,205 | 0 | 0 | 0 | For |
| Hartford | 460,983 | 0 | 0 | 0 | For |
| TIAA | 426,710 | 0 | 0 | 0 | For |
| Equitable | 179,048 | 0 | 0 | 0 | For |
| Northwestern Mutual | 115,697 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 111,060 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 108,915 | 0 | 0 | 0 | For |
| Brighthouse | 96,363 | 0 | 9,367 | 0 | For |
| John Hancock | 96,110 | 0 | 0 | 0 | For |
| DWS | 95,780 | 0 | 0 | 0 | For |
| JPMorgan | 77,880 | 0 | 0 | 0 | For |
| Lincoln Financial | 52,768 | 0 | 0 | 0 | For |
| MassMutual | 40,504 | 0 | 0 | 0 | For |
| New York Life | 38,343 | 0 | 0 | 0 | For |
| Global X | 37,966 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 15,624 | 19,391 | 0 | 0 | Against |
| ProShares | 32,980 | 0 | 0 | 0 | For |
| Transamerica | 32,668 | 0 | 0 | 0 | For |
Showing the 25 largest of 52 asset managers. See all 52 in the interactive database.
Meeting held 2025-06-05.
Combines 2 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
CELLDEX THERAPEUTICS INC.’s own tally for this item (“Elect Director: Herbert J. Conrad”): 53,051,316 for, 1,082,802 against, per its Form 8-K filed 2025-06-06 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 66,384,191 outstanding shares: 80% for, 2% against (82% of the company cast a for/against vote).
The 52 asset managers below cast 99.2% of the shares they voted on this item FOR (27,188,937 for, 219,247 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 9,127,282 | 0 | 0 | 0 | For |
| Fidelity | 5,682,038 | 4,436 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 3,736,784 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,525,742 | 0 | 0 | 0 | For |
| BlackRock | 1,772,221 | 158,656 | 0 | 0 | For |
| State Street | 1,012,770 | 40 | 0 | 0 | For |
| Charles Schwab | 537,823 | 0 | 0 | 0 | For |
| American Century | 496,205 | 0 | 0 | 0 | For |
| Hartford | 460,983 | 0 | 0 | 0 | For |
| TIAA | 426,710 | 0 | 0 | 0 | For |
| Equitable | 179,048 | 0 | 0 | 0 | For |
| Northwestern Mutual | 115,697 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 111,060 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 108,915 | 0 | 0 | 0 | For |
| Brighthouse | 96,363 | 0 | 9,367 | 0 | For |
| John Hancock | 96,110 | 0 | 0 | 0 | For |
| DWS | 95,780 | 0 | 0 | 0 | For |
| JPMorgan | 77,880 | 0 | 0 | 0 | For |
| Lincoln Financial | 52,768 | 0 | 0 | 0 | For |
| MassMutual | 40,504 | 0 | 0 | 0 | For |
| New York Life | 38,343 | 0 | 0 | 0 | For |
| Global X | 37,966 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 15,624 | 19,391 | 0 | 0 | Against |
| ProShares | 32,980 | 0 | 0 | 0 | For |
| Transamerica | 32,668 | 0 | 0 | 0 | For |
Showing the 25 largest of 52 asset managers. See all 52 in the interactive database.
Meeting held 2025-06-05.
Combines 2 wordings of this item as funds reported it.
99.4% Majority: yes · of votes cast
CELLDEX THERAPEUTICS INC.’s own tally for this item (“Elect Director: James J. Marino”): 53,832,714 for, 301,247 against, per its Form 8-K filed 2025-06-06 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 66,384,191 outstanding shares: 81% for, 0.5% against (82% of the company cast a for/against vote).
The 52 asset managers below cast 99.9% of the shares they voted on this item FOR (27,407,017 for, 1,167 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 9,127,282 | 0 | 0 | 0 | For |
| Fidelity | 5,686,474 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 3,736,784 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,525,742 | 0 | 0 | 0 | For |
| BlackRock | 1,930,877 | 0 | 0 | 0 | For |
| State Street | 1,012,810 | 0 | 0 | 0 | For |
| Charles Schwab | 537,823 | 0 | 0 | 0 | For |
| American Century | 496,205 | 0 | 0 | 0 | For |
| Hartford | 460,983 | 0 | 0 | 0 | For |
| TIAA | 426,710 | 0 | 0 | 0 | For |
| Equitable | 179,048 | 0 | 0 | 0 | For |
| Northwestern Mutual | 115,697 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 111,060 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 108,915 | 0 | 0 | 0 | For |
| Brighthouse | 96,363 | 0 | 9,367 | 0 | For |
| John Hancock | 96,110 | 0 | 0 | 0 | For |
| DWS | 95,780 | 0 | 0 | 0 | For |
| JPMorgan | 77,880 | 0 | 0 | 0 | For |
| Lincoln Financial | 52,768 | 0 | 0 | 0 | For |
| MassMutual | 40,504 | 0 | 0 | 0 | For |
| New York Life | 38,343 | 0 | 0 | 0 | For |
| Global X | 37,966 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 35,015 | 0 | 0 | 0 | For |
| ProShares | 32,980 | 0 | 0 | 0 | For |
| Transamerica | 32,668 | 0 | 0 | 0 | For |
Showing the 25 largest of 52 asset managers. See all 52 in the interactive database.
Meeting held 2025-06-05.
Combines 2 wordings of this item as funds reported it.
99.5% Majority: yes · of votes cast
CELLDEX THERAPEUTICS INC.’s own tally for this item (“Elect Director: Keith L. Brownlie”): 53,883,737 for, 250,401 against, per its Form 8-K filed 2025-06-06 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 66,384,191 outstanding shares: 81% for, 0.4% against (82% of the company cast a for/against vote).
The 52 asset managers below cast 100% of the shares they voted on this item FOR (27,408,184 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 9,127,282 | 0 | 0 | 0 | For |
| Fidelity | 5,686,474 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 3,736,784 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,525,742 | 0 | 0 | 0 | For |
| BlackRock | 1,930,877 | 0 | 0 | 0 | For |
| State Street | 1,012,810 | 0 | 0 | 0 | For |
| Charles Schwab | 537,823 | 0 | 0 | 0 | For |
| American Century | 496,205 | 0 | 0 | 0 | For |
| Hartford | 460,983 | 0 | 0 | 0 | For |
| TIAA | 426,710 | 0 | 0 | 0 | For |
| Equitable | 179,048 | 0 | 0 | 0 | For |
| Northwestern Mutual | 115,697 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 111,060 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 108,915 | 0 | 0 | 0 | For |
| Brighthouse | 96,363 | 0 | 9,367 | 0 | For |
| John Hancock | 96,110 | 0 | 0 | 0 | For |
| DWS | 95,780 | 0 | 0 | 0 | For |
| JPMorgan | 77,880 | 0 | 0 | 0 | For |
| Lincoln Financial | 52,768 | 0 | 0 | 0 | For |
| MassMutual | 40,504 | 0 | 0 | 0 | For |
| New York Life | 38,343 | 0 | 0 | 0 | For |
| Global X | 37,966 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 35,015 | 0 | 0 | 0 | For |
| ProShares | 32,980 | 0 | 0 | 0 | For |
| Transamerica | 32,668 | 0 | 0 | 0 | For |
Showing the 25 largest of 52 asset managers. See all 52 in the interactive database.
Meeting held 2025-06-05.
Combines 3 wordings of this item as funds reported it.
99.6% Majority: yes · of votes cast
CELLDEX THERAPEUTICS INC.’s own tally for this item (“Elect Director: Rita I. Jain, M.D.”): 53,914,572 for, 207,007 against, per its Form 8-K filed 2025-06-06 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 66,384,191 outstanding shares: 81% for, 0.4% against (82% of the company cast a for/against vote).
The 52 asset managers below cast 100% of the shares they voted on this item FOR (27,408,184 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 9,127,282 | 0 | 0 | 0 | For |
| Fidelity | 5,686,474 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 3,736,784 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,525,742 | 0 | 0 | 0 | For |
| BlackRock | 1,930,877 | 0 | 0 | 0 | For |
| State Street | 1,012,810 | 0 | 0 | 0 | For |
| Charles Schwab | 537,823 | 0 | 0 | 0 | For |
| American Century | 496,205 | 0 | 0 | 0 | For |
| Hartford | 460,983 | 0 | 0 | 0 | For |
| TIAA | 426,710 | 0 | 0 | 0 | For |
| Equitable | 179,048 | 0 | 0 | 0 | For |
| Northwestern Mutual | 115,697 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 111,060 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 108,915 | 0 | 0 | 0 | For |
| Brighthouse | 96,363 | 0 | 9,367 | 0 | For |
| John Hancock | 96,110 | 0 | 0 | 0 | For |
| DWS | 95,780 | 0 | 0 | 0 | For |
| JPMorgan | 77,880 | 0 | 0 | 0 | For |
| Lincoln Financial | 52,768 | 0 | 0 | 0 | For |
| MassMutual | 40,504 | 0 | 0 | 0 | For |
| New York Life | 38,343 | 0 | 0 | 0 | For |
| Global X | 37,966 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 35,015 | 0 | 0 | 0 | For |
| ProShares | 32,980 | 0 | 0 | 0 | For |
| Transamerica | 32,668 | 0 | 0 | 0 | For |
Showing the 25 largest of 52 asset managers. See all 52 in the interactive database.
Meeting held 2025-06-05.
Combines 3 wordings of this item as funds reported it.
99.7% Majority: yes · of votes cast
CELLDEX THERAPEUTICS INC.’s own tally for this item (“Proposal 2: The stockholders approved the ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025.”): 58,043,825 for, 119,347 against, per its Form 8-K filed 2025-06-06 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 66,384,191 outstanding shares: 87% for, 0.2% against (88% of the company cast a for/against vote).
The 52 asset managers below cast 99.9% of the shares they voted on this item FOR (27,406,977 for, 1,207 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 9,127,282 | 0 | 0 | 0 | For |
| Fidelity | 5,686,474 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 3,736,784 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,525,742 | 0 | 0 | 0 | For |
| BlackRock | 1,930,877 | 0 | 0 | 0 | For |
| State Street | 1,012,770 | 40 | 0 | 0 | For |
| Charles Schwab | 537,823 | 0 | 0 | 0 | For |
| American Century | 496,205 | 0 | 0 | 0 | For |
| Hartford | 460,983 | 0 | 0 | 0 | For |
| TIAA | 426,710 | 0 | 0 | 0 | For |
| Equitable | 179,048 | 0 | 0 | 0 | For |
| Northwestern Mutual | 115,697 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 111,060 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 108,915 | 0 | 0 | 0 | For |
| Brighthouse | 96,363 | 0 | 9,367 | 0 | For |
| John Hancock | 96,110 | 0 | 0 | 0 | For |
| DWS | 95,780 | 0 | 0 | 0 | For |
| JPMorgan | 77,880 | 0 | 0 | 0 | For |
| Lincoln Financial | 52,768 | 0 | 0 | 0 | For |
| MassMutual | 40,504 | 0 | 0 | 0 | For |
| New York Life | 38,343 | 0 | 0 | 0 | For |
| Global X | 37,966 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 35,015 | 0 | 0 | 0 | For |
| ProShares | 32,980 | 0 | 0 | 0 | For |
| Transamerica | 32,668 | 0 | 0 | 0 | For |
Showing the 25 largest of 52 asset managers. See all 52 in the interactive database.
Meeting held 2024-06-13 (outside the 2024-2025 season's 1 July to 30 June window; reported in this season's filings).
Combines 2 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
CELLDEX THERAPEUTICS INC.’s own tally for this item (“Proposal 4: The stockholders voted to approve, on an advisory, non-binding basis, the compensation for the Company's named executive officers as disclosed in the Proxy Statement.”): 54,182,916 for, 945,004 against, per its Form 8-K filed 2024-06-14 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 66,384,191 outstanding shares: 82% for, 1% against (83% of the company cast a for/against vote).
The 2 asset managers below cast 100% of the shares they voted on this item FOR (137 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| COLDSTREAM CAPITAL MANAGEMENT INC | 137 | 0 | 0 | 0 | For |
| Echo45 Advisors LLC | 0 | 0 | 0 | 0 | -- |
Ranked by the number of CELLDEX THERAPEUTICS INC. shares each manager voted on the most widely held ballot item of the 2024-2025 meeting, shown as a share of the 66,384,191 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Fidelity | 16.51% |
| 2 | Vanguard | 14.00% |
| 3 | Wellington | 11.44% |
| 4 | T. Rowe Price | 8.96% |
| 5 | Kynam Capital Management, LP | 6.94% |
| 6 | BlackRock | 5.66% |
| 7 | MUTUAL FUND SERIES TRUST | 5.63% |
| 8 | Commodore Capital LP | 5.54% |
| 9 | State Street | 4.98% |
| 10 | GEODE CAPITAL MANAGEMENT, LLC | 2.42% |
Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).
| Holder | % outstanding | Disclosure |
|---|---|---|
| Wellington Management | 12.58% | 13F |
| BlackRock | 8.32% | 13F |
| FMR (Fidelity) | 8.10% | 13F |
| FMR LLC | 7.32% | DEF14A |
| Vanguard Group | 5.87% | 13F |
| T. Rowe Price | 5.14% | 13F |
| COMMODORE CAPITAL LP | 5.05% | DEF14A |
| State Street | 4.23% | 13F |
| Point72 | 3.95% | 13F |
| Geode Capital | 2.39% | 13F |
Percentages above are of 66,384,191 shares outstanding, as reported by CELLDEX THERAPEUTICS INC. on its Form 10-Q dated 2025-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from CELLDEX THERAPEUTICS INC.’s 10-Q dated 2025-03-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.
At CELLDEX THERAPEUTICS INC.'s shareholder meeting held 2025-06-05, in the 2024-2025 proxy season, 190 asset managers reported how they voted on 13 ballot items in their SEC Form N-PX filings, covering 2,700 separate fund positions. On the most widely held item on that ballot — To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as… — FOR was 99% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: CELLDEX THERAPEUTICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2025-06-06.
CELLDEX THERAPEUTICS INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.